Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001593087-26-000007
Filing Date
2026-05-04
Accepted
2026-05-04 16:30:07
Documents
1
Period of Report
2026-05-01

Document Format Files

Seq Description Document Type Size
1 form4-05042026_040501.html 4  
1 form4-05042026_040501.xml 4 7528
  Complete submission text file 0001593087-26-000007.txt   9203
Mailing Address 10865 ROAD TO THE CURE SUITE 150 SAN DIEGO CA 92121
Business Address 10865 ROAD TO THE CURE SUITE 150 SAN DIEGO CA 92121 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CAPRICOR THERAPEUTICS, INC. 10865 ROAD TO THE CURE, SUITE 150 SAN DIEGO CA 92121
Business Address
Bergmann Anthony (Reporting) CIK: 0001593087 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34058 | Film No.: 26938176